PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30353642-4	2019	CUDC-907 inhibited PI3K/AKT and HDAC activity, as expected, but also suppressed RAF/MEK/ERK and STAT3 signalling and reduced the expression of anti-apoptotic BCL-2 family proteins BCL-2, BCL-xL, and MCL-1.	CUDC-907	0-8	AKT serine/threonine kinase 1	Homo sapiens	24-27	
30353642-4	2019	CUDC-907 inhibited PI3K/AKT and HDAC activity, as expected, but also suppressed RAF/MEK/ERK and STAT3 signalling and reduced the expression of anti-apoptotic BCL-2 family proteins BCL-2, BCL-xL, and MCL-1.	CUDC-907	0-8	mitogen-activated protein kinase kinase 7	Homo sapiens	84-87	
30353642-4	2019	CUDC-907 inhibited PI3K/AKT and HDAC activity, as expected, but also suppressed RAF/MEK/ERK and STAT3 signalling and reduced the expression of anti-apoptotic BCL-2 family proteins BCL-2, BCL-xL, and MCL-1.	CUDC-907	0-8	mitogen-activated protein kinase 1	Homo sapiens	88-91	
30353642-4	2019	CUDC-907 inhibited PI3K/AKT and HDAC activity, as expected, but also suppressed RAF/MEK/ERK and STAT3 signalling and reduced the expression of anti-apoptotic BCL-2 family proteins BCL-2, BCL-xL, and MCL-1.	CUDC-907	0-8	signal transducer and activator of transcription 3	Homo sapiens	96-101	
30353642-4	2019	CUDC-907 inhibited PI3K/AKT and HDAC activity, as expected, but also suppressed RAF/MEK/ERK and STAT3 signalling and reduced the expression of anti-apoptotic BCL-2 family proteins BCL-2, BCL-xL, and MCL-1.	CUDC-907	0-8	BCL2 apoptosis regulator	Homo sapiens	158-163	
30353642-4	2019	CUDC-907 inhibited PI3K/AKT and HDAC activity, as expected, but also suppressed RAF/MEK/ERK and STAT3 signalling and reduced the expression of anti-apoptotic BCL-2 family proteins BCL-2, BCL-xL, and MCL-1.	CUDC-907	0-8	BCL2 apoptosis regulator	Homo sapiens	180-185	
30353642-4	2019	CUDC-907 inhibited PI3K/AKT and HDAC activity, as expected, but also suppressed RAF/MEK/ERK and STAT3 signalling and reduced the expression of anti-apoptotic BCL-2 family proteins BCL-2, BCL-xL, and MCL-1.	CUDC-907	0-8	BCL2 like 1	Homo sapiens	187-193	
30353642-4	2019	CUDC-907 inhibited PI3K/AKT and HDAC activity, as expected, but also suppressed RAF/MEK/ERK and STAT3 signalling and reduced the expression of anti-apoptotic BCL-2 family proteins BCL-2, BCL-xL, and MCL-1.	CUDC-907	0-8	MCL1 apoptosis regulator, BCL2 family member	Homo sapiens	199-204	
30353642-5	2019	Moreover, CUDC-907 downregulated cytokines BAFF and APRIL and their receptors BAFFR, TACI, and BCMA, thus blocking BAFF-induced NF-kappaB signalling.	CUDC-907	10-18	TNF superfamily member 13b	Homo sapiens	43-47	
30353642-5	2019	Moreover, CUDC-907 downregulated cytokines BAFF and APRIL and their receptors BAFFR, TACI, and BCMA, thus blocking BAFF-induced NF-kappaB signalling.	CUDC-907	10-18	TNF receptor superfamily member 13C	Homo sapiens	78-83	
30353642-5	2019	Moreover, CUDC-907 downregulated cytokines BAFF and APRIL and their receptors BAFFR, TACI, and BCMA, thus blocking BAFF-induced NF-kappaB signalling.	CUDC-907	10-18	TNF receptor superfamily member 13B	Homo sapiens	85-89	
30353642-5	2019	Moreover, CUDC-907 downregulated cytokines BAFF and APRIL and their receptors BAFFR, TACI, and BCMA, thus blocking BAFF-induced NF-kappaB signalling.	CUDC-907	10-18	TNF receptor superfamily member 17	Homo sapiens	95-99	
30353642-5	2019	Moreover, CUDC-907 downregulated cytokines BAFF and APRIL and their receptors BAFFR, TACI, and BCMA, thus blocking BAFF-induced NF-kappaB signalling.	CUDC-907	10-18	TNF superfamily member 13b	Homo sapiens	78-82	
30353642-5	2019	Moreover, CUDC-907 downregulated cytokines BAFF and APRIL and their receptors BAFFR, TACI, and BCMA, thus blocking BAFF-induced NF-kappaB signalling.	CUDC-907	10-18	nuclear factor kappa B subunit 1	Homo sapiens	128-137	
30353642-6	2019	T cell chemokines CCL3/4/17/22 and phosphorylation of CXCR4 were also reduced by CUDC-907.	CUDC-907	81-89	C-C motif chemokine ligand 3	Homo sapiens	18-30	
30353642-6	2019	T cell chemokines CCL3/4/17/22 and phosphorylation of CXCR4 were also reduced by CUDC-907.	CUDC-907	81-89	C-X-C motif chemokine receptor 4	Homo sapiens	54-59	
30353642-8	2019	Indeed, combinations of low concentrations of CUDC-907 with inhibitors of BCL2, BTK, or the NF-kappaB pathway showed a potent synergistic effect.	CUDC-907	46-54	BCL2 apoptosis regulator	Homo sapiens	74-78	
30353642-8	2019	Indeed, combinations of low concentrations of CUDC-907 with inhibitors of BCL2, BTK, or the NF-kappaB pathway showed a potent synergistic effect.	CUDC-907	46-54	Bruton tyrosine kinase	Homo sapiens	80-83	
30353642-8	2019	Indeed, combinations of low concentrations of CUDC-907 with inhibitors of BCL2, BTK, or the NF-kappaB pathway showed a potent synergistic effect.	CUDC-907	46-54	nuclear factor kappa B subunit 1	Homo sapiens	92-101